Anita Gashi has built her career at the intersection of business and life sciences, driving the commercial growth of technology companies by securing adoption within pharma and biotech R&D and manufacturing teams. Notable mentions include roles at the TNO-spin off InnoGI (formerly TIM), and Boston-based computational modeling leader digiM Solutions. In her roles, Anita was responsible for achieving key revenue milestones and enabling these advanced platforms to scale globally. Having worked with companies such as AstraZeneca, Pfizer, Johnson & Johnson,  Genentech etc. as well as the US Food and Drug Administration, she collaborated with some of the brightest scientists and gained exposure to programs spanning the full drug development timeline.

Anita now serves as Director of AdJane, a vaccine innovator advancing programs based on engineered Outer Membrane Vesicle (OMV) technology. AdJane’s platform spans decades of scientific foundation and clinical validation within Intravacc – the research arm of NVI (Netherlands Vaccine Institute) and focuses on infectious diseases with large unmet medical needs. In her role, she leads the company’s strategic direction, organizational build-out and external engagement.

AdJane has a strong commitment to empowering women. Across Europe, women hold fewer than 25% of executive roles in biotech, underscoring the need for stronger representation in the industry. With both its leadership and advisory teams led by accomplished women, AdJane provides a platform for women to lead and contribute, ensuring that their perspectives help guide not only the company’s growth but also the broader future of vaccine innovation.